0000899243-20-016834.txt : 20200617 0000899243-20-016834.hdr.sgml : 20200617 20200617161412 ACCESSION NUMBER: 0000899243-20-016834 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krishnan Suma CENTRAL INDEX KEY: 0001298711 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38210 FILM NUMBER: 20969873 MAIL ADDRESS: STREET 1: 1861 PRATT DRIVE STREET 2: SUITE 1090 CITY: BLACKSBURG STATE: VA ZIP: 24060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Krystal Biotech, Inc. CENTRAL INDEX KEY: 0001711279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 821080209 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: (412) 586-5830 MAIL ADDRESS: STREET 1: 2100 WHARTON STREET STREET 2: SUITE 701 CITY: PITTSBURGH STATE: PA ZIP: 15203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-15 0 0001711279 Krystal Biotech, Inc. KRYS 0001298711 Krishnan Suma C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203 1 1 1 0 Chief Operating Officer Common Stock 2020-06-15 4 S 0 7578 41.3088 D 1928486 D Common Stock 2020-06-15 4 S 0 8652 42.2361 D 1919834 D Common Stock 2020-06-15 4 S 0 10740 43.2095 D 1909094 D Common Stock 2020-06-15 4 S 0 11311 44.5635 D 1897783 D Common Stock 2020-06-15 4 S 0 11719 45.0706 D 1886064 D Common Stock 112162 I By Trust Common Stock 1886462 I By Spouse The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person following discussions with the Compensation Committee and the Board of Directors. This transaction was executed in multiple trades ranging from $40.84 to $41.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $41.84 to $42.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide This transaction was executed in multiple trades ranging from $42.85 to $43.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $43.91 to $44.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. This transaction was executed in multiple trades ranging from $44.91 to $45.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Directly beneficially owned by the Krishnan Family Trust. The reporting person and her spouse are each joint beneficial owners of the trust with joint voting and investment control. Directly beneficially owned by Krish S. Krishnan, the spouse of the reporting person. /s/ Suma Krishnan 2020-06-17